The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation
Lourdes Serrano(Borough of Manhattan Community College), Alejandro Vaquero(Josep Carreras Leukaemia Research Institute), Purificacı́on Muñoz(Institut d'Investigació Biomédica de Bellvitge), Anna Marazuela-Duque(Institut d'Investigació Biomédica de Bellvitge), Dolors Fondevila(Universitat Autònoma de Barcelona), Jay A. Tischfield(Rutgers, The State University of New Jersey), Rosa M. Rabanal(Universitat Autònoma de Barcelona), Marcus Krüger(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), Scott Dooley(University of Pennsylvania), David B. Beck(Center for Human Genetics), Philipp Voigt(Babraham Institute), Noriko Kane‐Goldsmith(Rutgers, The State University of New Jersey), Paloma Martínez‐Redondo(Institut d'Investigació Biomédica de Bellvitge), Qiang Tong(Shandong University), Berta N. Vázquez(Rutgers, The State University of New Jersey)
Cited by 281
Related Papers
Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction
|Proceedings of the National Academy of Sciences|1998|1.1k
Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A
|Cell|1995|998
A double take on bivalent promoters
|Genes & Development|2013|846
Genome-wide search for genes affecting the risk for alcohol dependence
|American Journal of Medical Genetics|1998|739
The Failing Heart Relies on Ketone Bodies as a Fuel
|Circulation|2016|706